Holy Stone Healthcare Co., Ltd. (TPEX:4194)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.10
-0.06 (-0.84%)
Mar 10, 2026, 2:03 PM CST

Holy Stone Healthcare Revenue

Holy Stone Healthcare had revenue of 47.51M TWD in the twelve months ending June 30, 2025, down -78.63% year-over-year. In the year 2024, Holy Stone Healthcare had annual revenue of 118.77M, down -49.86%.

Revenue (ttm)
47.51M
Revenue Growth
-78.63%
P/S Ratio
22.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.05B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024118.77M-118.12M-49.86%
Dec 31, 2023236.89M-33.35M-12.34%
Dec 31, 2022270.24M53.16M24.49%
Dec 31, 2021217.08M-4.51M-2.04%
Dec 31, 2020221.60M17.44M8.54%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Level Biotechnology 736.59M
Lukas Biomedical 180.32M
GeneReach Biotechnology 215.32M
Taiwan Advance Bio-Pharmaceutical 371.86M
Enimmune 42.23M
TCI GENE 324.73M
NatureWise Biotech & Medicals 180.29M
Neith 39.35M
Revenue Rankings